Valuation: Star Scientific, Inc.

Market Cap 153K 135K 127K 116K 217K 14.7M 218K 1.52M 589K 7.51M 576K 563K 24.14M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.56M 16.58M 15.11M 28.29M 1.92B 28.49M 198M 76.86M 980M 75.13M 73.51M 3.15B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%+2.65%+63.34%+115.27% 1,055B
-0.40%+0.46%+50.92%+72.63% 654B
-0.12%+0.14%+19.82%+72.62% 467B
-1.36%-2.47%+38.93%+42.49% 348B
+1.45%+4.75%+22.83%+29.83% 275B
-0.25%-0.11%+13.15%+13.99% 258B
-0.63%+7.51%+51.88%+54.14% 224B
-0.98%+0.55%+34.64%+99.77% 187B
-0.03%-2.90%-28.18%-61.25% 171B
Average -0.34%+0.74%+29.70%+48.83% 404.26B
Weighted average by Cap. -0.37%+1.32%+40.10%+68.70%

Financials

2014 2015
Net sales - -
Net income -38.52M -33.8M -31.92M -29.09M -54.46M -3.69B -54.84M -382M -148M -1.89B -145M -141M -6.06B -6.84M -6.01M -5.67M -5.17M -9.68M -656M -9.75M -67.88M -26.29M -335M -25.7M -25.14M -1.08B
Net Debt -45K -39.49K -37.29K -33.99K -63.62K -4.31M -64.08K -446K -173K -2.2M -169K -165K -7.08M 19.86M 17.42M 16.46M 15M 28.07M 1.9B 28.27M 197M 76.27M 972M 74.56M 72.94M 3.12B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-